You have 9 free searches left this month | for more free features.

Lymphoma, B-Cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer

Not yet recruiting
  • Breast Cancer
  • blood sample collection.
  • (no location specified)
Jan 21, 2021

Viral Hepatitis B and C at PASS Consultation of Montpellier

Recruiting
  • Hepatitis C
  • +2 more
    • Montpellier, Hérault, France
      CHU Montpellier, St Eloi Hospital,
    Dec 16, 2021

    NSCLC Trial in Guangzhou (Surufatinib,Toripalimab,Pemetrexed,Carboplatin/Cisplatin)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Guangzhou, Guang Dong, China
      Sun Yat-sen University Cancer Center
    Nov 3, 2022

    Head Neck Cancer, Human Papilloma Virus Trial in United States (MEDI0457, CELLECTRA®5P device, Durvalumab)

    Completed
    • Head and Neck Cancer
    • Human Papilloma Virus
    • San Francisco, California
    • +13 more
    Aug 3, 2022

    Frozen Shoulder Trial in Rawalpindi (Gong Mobilization, Kaltenborn Mobilization)

    Completed
    • Frozen Shoulder
    • Gong Mobilization
    • Kaltenborn Mobilization
    • Rawalpindi, Punjab, Pakistan
    • +1 more
    Jun 26, 2023

    Vaccine Reaction Trial in Erzurum (shotblocker, lullaby)

    Recruiting
    • Vaccine Reaction
    • shotblocker
    • lullaby
    • Erzurum, Center, Turkey
      Ataturk University Nursing of Faculty
    Oct 25, 2022

    S-ICD Electrode Registry

    Not yet recruiting
    • ICD Malfunction
    • Sudden Cardiac Death
      • Cologne, NRW, Germany
        University Hospital Cologne
      Jan 27, 2023

      Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

      Recruiting
      • Anatomic Stage II Breast Cancer AJCC v8
      • +19 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      May 11, 2022

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

      Recruiting
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • Des Moines, Iowa
      • +8 more
      Jan 12, 2023

      Philadelphia-Negative ALL, High-Risk Cancer Trial in Israel (Blinatumomab)

      Recruiting
      • Philadelphia-Negative ALL
      • High-Risk Cancer
      • Haifa, Israel
      • +3 more
      May 6, 2021

      Skin Laxity Trial in Birmingham, Houston (BTL-585-2 RF+US, BTL-585-2 RF)

      Completed
      • Skin Laxity
      • BTL-585-2 RF+US
      • BTL-585-2 RF
      • Birmingham, Michigan
      • +1 more
      Jun 29, 2023

      Pregnancy and Anxious Thoughts: The Role of Immune and Endocrine

      Completed
      • Perinatal Anxiety
      • Coping with Anxiety through Living Mindfully (CALM) Pregnancy
      • Baltimore, Maryland
        Women's Mood Disorders Center
      Jan 9, 2023

      Small Cell Lung Cancer Trial (Rovalpituzumab tesirine)

      Completed
      • Small Cell Lung Cancer
      • Rovalpituzumab tesirine
      • (no location specified)
      Jul 28, 2021

      Multiple Myeloma Trial in Lanzhou (Pomalidomide)

      Recruiting
      • Multiple Myeloma
      • Lanzhou, Gansu, China
        The First Hospital of Lanzhou University
      Jul 9, 2022

      Breast Tumors Trial in Worldwide (pembrolizumab, paclitaxel, nab-paclitaxel)

      Recruiting
      • Breast Neoplasms
      • pembrolizumab
      • +6 more
      • Tucson, Arizona
      • +188 more
      Aug 11, 2022

      Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in United States (melphalan, dexamethasone, bortezomib)

      Completed
      • Light Chain Deposition Disease
      • Primary Systemic Amyloidosis
      • Scottsdale, Arizona
      • +208 more
      Jan 12, 2022

      Sickle Cell Disease, Thalassemia Trial in Memphis (Hydroxyurea, Hydroxyurea Oral Capsule)

      Terminated
      • Sickle Cell Disease
      • Thalassemia
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Feb 18, 2022

      Parent-Child Relations Trial in Calgary (ATTACH™ Parenting Program)

      Recruiting
      • Parent-Child Relations
      • ATTACH™ Parenting Program
      • Calgary, Alberta, Canada
        University of Calgary
      Jul 11, 2022

      Exercise Performance, Fatigue Trial in Taoyuan (Placebo, EX plus)

      Completed
      • Exercise Performance
      • Fatigue
      • Placebo
      • EX plus
      • Taoyuan, Taiwan
        Graduate Institute of Sports Science, National Taiwan Sport Univ
      Oct 17, 2022

      Sickle Cell Disease Trial in Marseille (osteopathic manipulative therapy, sham osteopathic manipulative therapy)

      Recruiting
      • Sickle Cell Disease
      • osteopathic manipulative therapy
      • sham osteopathic manipulative therapy
      • Marseille, Paca, France
        Collège Ostéopathique de Provence Aix-Marseille
      Nov 18, 2022

      Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer Trial in Los Angeles (radiation, other, drug)

      Active, not recruiting
      • Adenocarcinoma of the Lung
      • +8 more
      • hypofractionated radiation therapy
      • +5 more
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center
      Dec 2, 2021

      Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma Trial in China (TQB2618 injection,

      Not yet recruiting
      • Recurrent Squamous Cell Carcinoma of the Head and Neck
      • Metastatic Squamous Cell Carcinoma
      • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
      • Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
      • Lanzhou, Gansu, China
      • +11 more
      Mar 23, 2023

      HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

      Completed
      • HER2-positive Breast Cancer
      • +8 more
      • San Francisco, California
        University of California, San Francisco
      Jan 6, 2023

      Advanced Cholangiocarcinoma Trial in Hangzhou (Lenvatinib, tislelizumab, gemcitabine and cisplatin, Gemcitabine and cisplatin)

      Not yet recruiting
      • Advanced Cholangiocarcinoma
      • Lenvatinib, tislelizumab, gemcitabine and cisplatin
      • Gemcitabine and cisplatin
      • Hangzhou, Zhejiang, China
        The Second Affiliated Hospital, Zhejiang University School of Me
      Apr 10, 2023

      NSCLC Trial in Liège (induced sputum, lung biopsy, bronchoalveolar lavage)

      Recruiting
      • Non-small Cell Lung Cancer
      • induced sputum
      • +3 more
      • Liège, Belgium
        CHU de Liège
      Nov 7, 2022